Terug
Dagbereik
€ 194,43
€ 203,44
52-Weeksbereik
€ 109,82
€ 247,21
Volume
1.012.818
50D / 200D Gem.
€ 213,36
/
€ 194,00
Vorige Slotkoers
€ 203,41
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 12,5 | 0,3 |
| P/B | 4,2 | 2,9 |
| ROE % | 33,5 | 3,7 |
| Net Margin % | 6,6 | 3,8 |
| Rev Growth 5Y % | 2,3 | 10,0 |
| D/E | 3,1 | 0,2 |
Koersdoel Analisten
Hold
€ 258,55
+29.5%
Low: € 224,00
High: € 288,00
Forward K/W
11,9
Forward WPA
€ 17,16
WPA Groei (sch.)
+0,0%
Omzet Sch.
22 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 23,74
€ 23,20 – € 24,30
|
24 B | 2 |
| FY2028 |
€ 19,99
€ 16,13 – € 22,12
|
24 B | 4 |
| FY2027 |
€ 17,56
€ 15,32 – € 20,52
|
22 B | 12 |
Belangrijkste Punten
Revenue grew 2,26% annually over 5 years — modest growth
Earnings declined -56,03% over the past year
ROE of 33,54% indicates high profitability
Debt/Equity of 3,12 — high leverage
Generating 2,53B in free cash flow
P/E of 12,47 — trading at a low valuation
Groei
Revenue Growth (5Y)
2,26%
Revenue (1Y)3,12%
Earnings (1Y)-56,03%
FCF Growth (3Y)24,85%
Kwaliteit
Return on Equity
33,54%
ROIC15,13%
Net Margin6,60%
Op. Margin16,46%
Veiligheid
Debt / Equity
3,12
Current Ratio1,76
Interest Coverage0,00
Waardering
P/E Ratio
12,47
P/B Ratio4,16
EV/EBITDA7,93
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3,12% | Revenue Growth (3Y) | 1,84% |
| Earnings Growth (1Y) | -56,03% | Earnings Growth (3Y) | 51,75% |
| Revenue Growth (5Y) | 2,26% | Earnings Growth (5Y) | 11,39% |
| Profitability | |||
| Revenue (TTM) | 21,31B | Net Income (TTM) | 1,41B |
| ROE | 33,54% | ROA | 4,74% |
| Gross Margin | 41,41% | Operating Margin | 16,46% |
| Net Margin | 6,60% | Free Cash Flow (TTM) | 2,53B |
| ROIC | 15,13% | FCF Growth (3Y) | 24,85% |
| Safety | |||
| Debt / Equity | 3,12 | Current Ratio | 1,76 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 12,47 | P/B Ratio | 4,16 |
| P/S Ratio | 0,82 | PEG Ratio | -0,24 |
| EV/EBITDA | 7,93 | Dividend Yield | 0,00% |
| Market Cap | 17,54B | Enterprise Value | 27,83B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 21,31B | 20,67B | 20,55B | 19,17B | 19,49B |
| Net Income | 1,41B | 3,20B | 611,00M | 411,00M | 914,00M |
| EPS (Diluted) | 15,49 | 32,70 | 5,71 | 3,79 | 8,42 |
| Gross Profit | 8,83B | 8,21B | 7,81B | 7,05B | 7,27B |
| Operating Income | 3,51B | 5,96B | 2,51B | 2,33B | 2,87B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 29,68B | 28,94B | 28,31B | 27,16B | 27,58B |
| Total Liabilities | 20,70B | 20,39B | 22,80B | 22,55B | 23,32B |
| Shareholders' Equity | 4,22B | 4,17B | 1,61B | 1,14B | 1,03B |
| Total Debt | 13,17B | 14,33B | 15,00B | 15,08B | 15,65B |
| Cash & Equivalents | 2,88B | 3,02B | 1,23B | 858,00M | 2,36B |
| Current Assets | 7,85B | 7,68B | 7,17B | 5,98B | 7,08B |
| Current Liabilities | 4,46B | 4,31B | 4,76B | 4,48B | 5,11B |